281-296-7300

  • Awards
  • Careers
logo
  • About
    • About VGXI
    • Leadership
    • VGXI Mission
    • Awards
    • Careers
  • Services
    • Manufacturing Services
    • cGMP Plasmid
    • HD Plasmid
    • Pre-Clinical Plasmid
    • Additional Services
  • VGXI Process
    • VGXI Manufacturing Process
    • Analytical Testing
    • Quality Systems
  • Resource Center
    • News
    • Events
    • FAQs
    • Whitepapers
    • Posters & Presentations
  • Contact Us
  • Awards
  • Careers

Year: 2022

VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility

October 10, 2022

VGXI, a plasmid DNA contract manufacturer, celebrated the official grand opening and ribbon cutting for its new headquarters and manufacturing facility located in Conroe, TX on Friday, October 7, 2022.

Filed Under: Events, News

An Introduction to DNA and Vaccines

August 25, 2022

Vaccines are one of humanity’s most important inventions as they help protect public health and save millions of lives every year. By stimulating the body’s immune system to elicit an immune response, vaccines have protected people from deadly diseases such as smallpox, rinderpest, and malaria, among others. Traditionally, vaccines are made from weak or inactivated… Read More »

Filed Under: Blog

VGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility

August 17, 2022

Specialized plasmid DNA contract manufacturer VGXI, Inc. announces date for the Grand Opening celebration of its new headquarters and expanded manufacturing facility in Conroe, TX. VGXI, Inc., an industry-leading contract developer and manufacturer (CDMO) of nucleic acid biopharmaceuticals including gene therapies, DNA vaccines, and RNA medicines, announces the official Grand Opening celebration for its new… Read More »

Filed Under: Events, News

VGXI Celebrates First Look Event at New Manufacturing Facility

April 18, 2022

VGXI opened the doors of its new headquarters and manufacturing facility on 09Apr22 to provide friends and employee families a first look inside and outside the new site! As production is nearing completion, the event was an opportunity for employees and their families to tour the production suites, labs, and office spaces before the official… Read More »

Filed Under: News

VGXI Official COVID-19 Statement

March 31, 2022

To our Valued Clients and Business Partners, VGXI’s top priority is to continue delivering the highest quality DNA products and services while ensuring the security and safety of our team. VGXI is actively monitoring the evolving situation and will continue to provide updates as new information becomes available. Manufacturing activities have been maintained throughout the… Read More »

Filed Under: Blog, Events, Media, News, Sticky Post

VGXI Partner IMM Announces $12M NIH Grant to Support Phase 1 Clinical Trial of a DNA Vaccine for the Prevention of Alzheimer’s Disease

March 30, 2022

Texas-based CDMO VGXI, Inc. is excited to announce that its partner, The Institute for Molecular Medicine, has recently been awarded a $12 million NIA grant to support clinical testing of a novel DNA vaccine manufactured by VGXI for the prevention of Alzheimer’s Disease. The Woodlands, TX – VGXI, Inc., an industry recognized contract developer and… Read More »

Filed Under: General

Archives

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • About
  • Services
  • VGXI Process
  • Contact Us
  • Careers
  • Awards
  • Resource Center
logo white

281-296-7300
2700 Research Forest Drive, Suite 180
The Woodlands, Texas 77381, USA

Teko Font
Please enter your name.
Please enter a valid email address.
Sign Up

Thanks for subscribing! Please check your email for further instructions.

Something went wrong. Please check your entries and try again.

© 2021 VGXI, Inc. All Rights Reserved.Terms | Privacy Policy